Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565338
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Comparison Between Effect of Vitamin D Versus Dexmedetomidine in Patients With Head Trauma Using Interleukin 6
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison Between the Neuroprotective Effect of Vitamin D Versus Dexmedetomidine in Patients With Traumatic Brain Injury Using Interleukin 6 as Inflammatory Marker
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
in this study the investigators compare between the neuroprotective effect of vitamin d versus dexmedetomidine in patients with traumatic brain injury using interleukin 6 as inflammatory biomarker
Detailed Description:
patients with moderate head trauma GCS 8-12 within first 24 hours were randomly divided into 2 groups first group received 100000 IU of vitamin D was given IM the other group received dexmedetomidine 04 mickg as loading dose then 025 mickghr as maintainence dose for 5 days detecting APATCHE at admission and following up of vital signs HR NIBP investigations CBC RFT ABG ESR CRP IL-6 GCS and GOS for 5 days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None